Direct Medical Costs of Kidney Stone: A Retrospective Study LC52-LC58
Trung Quang Vo.,
Department of Pharmacy Administration, Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City,
Ho Chi Minh City 700000, Vietnam.
Introduction: Nephrolithiasis imposes a weighty economic burden on individuals and their families, the healthcare system, and society. In Vietnam, expenses related to nephrolithiasis are poorly investigated.
Aim: To assess the direct medical cost of treating nephrolithiasis and provide data on the economic burden of kidney stone disease in actual clinical practice in Vietnam.
Materials and Methods: A retrospective costs approach from a hospital perspective was employed. Data was collected from Binh-Dan Hospital â€“ a public hospital in Ho Chi Minh City, Vietnam, to estimate direct medical costs. The Bootstraping method of 2,000 times of resampling was used due to a skewed data.
Results: A total of 57,332 nephrolithiasis patients from Binh- Dan Hospital were enrolled in the study. Throughout the study period, the per-episode direct medical cost of nephrolithiasis in the Inpatient Department (IPD) and outpatient department (OPD) was US$ 532.1 (95% CI, 524.8-539.9) and US$ 50.1 (95% CI, 49.7-50.4), respectively. The two most significant components of direct medical cost were medical procedures (24.7%) and pharmaceuticals (20.2%).
Conclusion: The findings indicate that nephrolithiasis places a considerable economic burden on public healthcare services in Vietnam. Analysis demonstrating the magnitude of the economic impact of nephrolithiasis management in Vietnamâ€™s healthcare system may help facilitate health and social policy interventions to improve the prevention and treatment of nephrolithiasis.